Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Rheumatoid arthritis patients with active or stable, well controlled disease and control individuals

From: Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

Parameter Controls Active RA OA RA in remission
n 34 28 12 36
Age (mean ± standard deviation [range]; years) 48 ± 16 (24–62) 51 ± 17 (20–83) 60 ± 9 (49–73) 48 ± 11 (25–67)
Sex (male/female) 6/17 9/28 3/9 7/29
Disease duration (mean ± standard deviation [range]; years) NA 5.1 ± 7.5 (0.1–37) NA 9.3 ± 6.8 (2–28)
Remission duration (mean ± standard error [range]; months) NA NA NA 29 ± 29 (6–144)
CRP (mean ± standard deviation [range]; mg/l), below /above detectiona NA 55 ± 52 (5–164), 0/28 NA 3.5 ± 5.2 (0–12), 23/13
  1. aC-reactive protein (CRP) values <5 mg/l are considered below the detection range. CRP values <10 mg/l are considered normal among the local population. NA, not applicable; OA, osteoarthritis; RA, rheumatoid arthritis.